Abstract
Objectives To examine the effects of food ingestion and administered dose on the absorption of oral micronized P (Utrogestan; Besins-Iscovesco, Paris, France) and to compare the bioavailability of intramuscular versus oral routes of administration.
Design Prospective, randomized, open label crossover protocol with 7 days between dosages.
Setting Academic institution.
Participants Fifteen normal postmenopausal women.
Interventions All subjects participated in three separate protocols: [1] micronized P (200 mg) or placebo under fasting or nonfasting conditions once daily for 5 days; [2] micronized P (100, 200, or 300 mg) once daily under fasting conditions for 5 days; and [3] micronized P (200 mg) or intramuscular P (50 mg in oil) administered once daily for 2 days.
Main outcome measures Serum P concentrations were measured in all groups.
Results Concomitant food ingestion increased the area under the serum P concentration versus time curve (AUC0 to 24) and the maximum serum P concentration (Cmax) without affecting time to maximum serum concentration (Tmax) (P < 0.05). Micronized P absorption and elimination were first-order processes and exhibited dose-independent pharmacokinetics between 100 and 300 mg. After intramuscular P, Cmax was higher and Tmax occurred later compared with the oral P preparation. Oral P had lower relative bioavailability (8.6%) than intramuscular P.
Conclusions Absorption of micronized P was enhanced twofold in the presence of food. Both absorption and elimination were dose-independent, dose proportionality being confirmed. Bioavailability of the oral P was approximately 10% compared with intramuscular P.
oral micronized progesterone absorption, progesterone bioavailability food effect, prometrium pharmacokinetics, oral versus intramuscular progesterone, progesterone supplementation timing, luteal phase support dosing, micronized progesterone dose proportionality, progesterone with food absorption, optimal progesterone administration, naprotechnology progesterone protocol, serum progesterone levels oral
Keywords
Administration, Oral, Adult, Aged, Biological Availability, Drug Compounding, Eating, Fasting/metabolism, Female, Half-Life, Humans, Injections, Intramuscular, Intestinal Absorption, Menopause/metabolism, Middle Aged, Progesterone/administration & Dosage/blood/pharmacokinetics, Prospective Studies, Progesterone,